Canada has approved the first-way drug for many myeloma, a significant advancement in the treatment of a cancer that has no cure, undergoing frequent cycles with patients and relaxes.
Myeloma is a cancer of bone marrow and blood, which is easily confused by the name with melanoma, which is a severe skin disease. The disease is formed in plasma cells, which when healthy, forming antibodies fighting infections.
“When the infection goes on, they should be silent. In the myeloma, when the invader goes, it does not stop, and it crosses the line to become cancer. So it grows in the bone marrow and grows,” Dr. Donna Recee, one of the leading Canadian officials on several Mayaloma in Canada, describes it.
The myeloma leads to the destruction of the bone and often presents as fatigue and back pain, is common for many, and that is why it often becomes undesirable.
In this way, Mary Ann Tuomomi revealed the multiple myeloma at the age of 58.
“In May of 2021, I was teaching from a distance, and I had severe, severe back pain. I tried ciropracters, physiotherapists, even bought an adjustable bed,” she said. “I ended in the hospital and spent two weeks in the hospital with a compression fracture on a vertebra.”
Four years later, after chemotherapy and a stem cell transplant, toomomi is on continuous maintenance treatment to slow down its growth.
“It is expected to work for a while, but eventually will re -handle those myeloma cells.
Dr. Reece states that a new drug approved by Health Canada, known as antibodies-drag conjugation, has a unique mechanism in the unique mechanism that can provide years of disease control. Patients are administered after passing through a pre -line of stem cell transplant and therapy.
“Balenrep is an antibody made in the laboratory to stick to the mileoma cells. It does not just stick to the tumor cell and neutralizes it; it has a poison that is attached to it that is then targeting the Myeloma cell and kills it,” says the ress “. “One of the benefits of this drug on other immune treatments is that we call it off-the-chest. So you can order it, patients can go into chemo suite, and there is no need to prepare it in any way.”
Reece states that Vikas Myeloma treatment is an important addition to the toolbox.
“I told the patients that the strategy is like beads in a series. Each treatment is a bead, and by the time we have another bead, when the disease is reusted, we can suppress it. There are many immune remedies. As a group of therapy, as a group of therapy, myloma care and other cancer, so far, have yet been clearly changed.”
Tumi states that when his father was given the same disease at the age of 80 in 2020, he was given three to five years as new courses of current research and treatment were not available.
“But with all the new remedies, I am expecting 20, 25 years, and every time new research and a new drug is available to a patient that gives another course of treatment available to them, it gives a person hope that they are going to be able to live a long life.”